List view / Grid view
Mount Sinai shows the potential link between Parkinson's disease and inflammatory bowel disease, suggests anti-TNFα therapy may reduce the risk of developing Parkinson's...
The FDA has approved Crysvita, the first drug approved to treat adults and children ages 1 year and older with x-linked hypophosphatemia, a rare, inherited form of rickets...
One class of drug used to treat type 2 diabetes may not reduce the risk of death when compared with placebo, suggests new findings...
Two common iron compounds increase the formation of a known biomarker for cancer...
In this In-Depth Focus; early biotherapeutic lead optimisation for more efficient drug discovery and development, and turning promising compounds into drug candidates.
Researchers aim to develop a new immunotherapy that could alter the immune reactions to food. The result: Extended relief from peanut allergies...
GB Sciences, Inc. is planning to file an Exploratory IND and perform a Phase 0 Clinical Trial to gather valuable First-In-Human data on its proprietary cannabis-based therapies...
In this issue; recent developments in turning promising compounds into drug candidates, reviewing the latest trends in pharmaceutical microbiology and their implications, and a roundtable debate featuring the views of five industry leaders.
Scientists have developed a new drug treating skin lesions in tuberous sclerosis complex (TSC), a rare intractable disease...
Sirolimus, which is used to prevent rejection after kidney transplants has been used to treat idiopathic pulmonary neuroendocrine cell hyperplasia...
New research points to the important role that benzodiazepines may have in depression...
A new cancer drug has proven safe and effective for paediatric patients with a rare tumour gene mutation...
Researchers develop a better delivery system for anti-inflammatory therapies...
Researchers have used kappa-carrageenan and nanosilicates to form injectable hydrogels to promote haemostasis and facilitate wound healing...
Combined treatment with two cancer immunotherapy drugs significantly prolonged survival in aggressive cancer malignant mesothelioma...
